Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Chigaev

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|July 8, 2003
Alpha4beta1 integrin affinity changes govern cell adhesionAlexandre Chigaev, Gordon Zwartz, Steven W Graves, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Dysregulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cellsValerie Hernandez-Hansen, Alexander J Smith, Zurab Surviladze, et al.
Molecular Biology of the Cell|November 8, 2014
FRET detection of lymphocyte function-associated antigen-1 conformational extensionAlexandre Chigaev, Yelena Smagley, Mark K Haynes, et al.
Oncotarget|April 21, 2015
CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21Sylvia Ganghammer, Evelyn Hutterer, Elisabeth Hinterseer, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALLDominique R Perez, Christian K Nickl, Anna Waller, et al.
Leukemia|February 23, 2020
TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemiaEva Szenes, Andrea Härzschel, Sarah Decker, et al.
The Journal of Biological Chemistry|February 6, 2013
Characterization of a Cdc42 protein inhibitor and its use as a molecular probeLin Hong, S Ray Kenney, Genevieve K Phillips, et al.
Haematologica|July 4, 2020
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidityJulia C Gutjahr, Elisabeth Bayer, Xiaobing Yu, et al.
The Journal of Experimental Medicine|January 6, 2018
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemiaErika Tissino, Dania Benedetti, Sarah E M Herman, et al.
Drug Discovery Today. Therapeutic Strategies|February 28, 2012
Drug Repurposing from an Academic PerspectiveTudor I Oprea, Julie E Bauman, Cristian G Bologa, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|July 8, 2003
Alpha4beta1 integrin affinity changes govern cell adhesionAlexandre Chigaev, Gordon Zwartz, Steven W Graves, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Dysregulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cellsValerie Hernandez-Hansen, Alexander J Smith, Zurab Surviladze, et al.
Molecular Biology of the Cell|November 8, 2014
FRET detection of lymphocyte function-associated antigen-1 conformational extensionAlexandre Chigaev, Yelena Smagley, Mark K Haynes, et al.
Oncotarget|April 21, 2015
CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21Sylvia Ganghammer, Evelyn Hutterer, Elisabeth Hinterseer, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALLDominique R Perez, Christian K Nickl, Anna Waller, et al.
Leukemia|February 23, 2020
TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemiaEva Szenes, Andrea Härzschel, Sarah Decker, et al.
The Journal of Biological Chemistry|February 6, 2013
Characterization of a Cdc42 protein inhibitor and its use as a molecular probeLin Hong, S Ray Kenney, Genevieve K Phillips, et al.
Haematologica|July 4, 2020
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidityJulia C Gutjahr, Elisabeth Bayer, Xiaobing Yu, et al.
The Journal of Experimental Medicine|January 6, 2018
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemiaErika Tissino, Dania Benedetti, Sarah E M Herman, et al.
Drug Discovery Today. Therapeutic Strategies|February 28, 2012
Drug Repurposing from an Academic PerspectiveTudor I Oprea, Julie E Bauman, Cristian G Bologa, et al.
Pageof 5